Dorsey Wright & Associates Purchases 47,288 Shares of Sabra Healthcare REIT, Inc. $SBRA

Dorsey Wright & Associates increased its position in Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) by 280.5% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 64,147 shares of the real estate investment trust’s stock after acquiring an additional 47,288 shares during the quarter. Dorsey Wright & Associates’ holdings in Sabra Healthcare REIT were worth $1,234,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. lifted its holdings in Sabra Healthcare REIT by 1.4% during the fourth quarter. Vanguard Group Inc. now owns 35,430,016 shares of the real estate investment trust’s stock valued at $671,045,000 after purchasing an additional 481,231 shares during the last quarter. Principal Financial Group Inc. increased its stake in shares of Sabra Healthcare REIT by 0.4% in the first quarter. Principal Financial Group Inc. now owns 25,052,121 shares of the real estate investment trust’s stock worth $481,755,000 after purchasing an additional 98,770 shares in the last quarter. Nuveen LLC increased its stake in shares of Sabra Healthcare REIT by 28.6% in the fourth quarter. Nuveen LLC now owns 7,303,254 shares of the real estate investment trust’s stock worth $138,324,000 after purchasing an additional 1,625,072 shares in the last quarter. Geode Capital Management LLC raised its position in shares of Sabra Healthcare REIT by 2.9% in the fourth quarter. Geode Capital Management LLC now owns 7,018,556 shares of the real estate investment trust’s stock valued at $132,949,000 after purchasing an additional 198,118 shares during the period. Finally, Bank of America Corp DE raised its position in shares of Sabra Healthcare REIT by 9.4% in the third quarter. Bank of America Corp DE now owns 5,224,116 shares of the real estate investment trust’s stock valued at $97,378,000 after purchasing an additional 447,528 shares during the period. 99.40% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on SBRA shares. UBS Group dropped their price target on shares of Sabra Healthcare REIT from $22.00 to $21.00 and set a “neutral” rating on the stock in a research note on Wednesday, July 8th. Raymond James Financial began coverage on shares of Sabra Healthcare REIT in a research note on Wednesday, June 17th. They issued an “underperform” rating for the company. Wall Street Zen raised shares of Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a report on Sunday, June 28th. Barclays started coverage on Sabra Healthcare REIT in a research report on Tuesday, July 7th. They set an “overweight” rating and a $21.00 target price on the stock. Finally, Weiss Ratings cut Sabra Healthcare REIT from a “buy (b+)” rating to a “buy (b)” rating in a research report on Thursday, June 4th. Five analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $21.45.

Sabra Healthcare REIT Trading Down 0.2%

Shares of Sabra Healthcare REIT stock opened at $20.11 on Friday. Sabra Healthcare REIT, Inc. has a 12-month low of $17.17 and a 12-month high of $21.28. The company has a market cap of $5.07 billion, a price-to-earnings ratio of 31.92, a PEG ratio of 1.50 and a beta of 0.65. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. The company’s 50-day moving average price is $19.60 and its 200-day moving average price is $19.74.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, meeting the consensus estimate of $0.16. The company had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. Sabra Healthcare REIT’s revenue for the quarter was up 20.9% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. On average, equities analysts expect that Sabra Healthcare REIT, Inc. will post 1.5 earnings per share for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Friday, May 15th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 6.0%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 190.48%.

Sabra Healthcare REIT Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.